Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in migraine
IRCT20250525065882N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in migraine comparing Lacosamide with Placebo (2 arms). Primary endpoints: Change in CGRP-LI levels and Change in migraine severity. Started Jun 2025; status: completed.
02
Drugs
lacosamide
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20250525065882N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250525065882N1.